Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]

0 reported adverse events

These side effects are most commonly reported by patients taking drugs of the Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] class:

# Side effect Count
See all common reactions for Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]

Drugs of the Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
See all enriched reactions for Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]